Literature DB >> 35738601

Error Detectability of Isodose Volumes as ROIs in Prostate Intensity-modulated RT QA.

Ryuta Nakahara1,2, Masayuki Fujiwara3, Haruyuki Takaki1, Masao Tanooka1, Kentaro Ishii2, Ryu Kawamorita2, Koichiro Yamakado1.   

Abstract

BACKGROUND/AIM: To evaluate the quality of error detectability with a three-dimensional verification system using isodose volumes as regions of interest (ROIs) in quality assurance (QA) of intensity-modulated radiation therapy. PATIENTS AND METHODS: Treatment plans with four types of intentional errors were created from the data of 20 patients with localized prostate cancer. These plans underwent QA using the three-dimensional verification system. The datasets of another 30 cases without inserted errors were assessed as controls. The ROIs used in the evaluations were those used in our conventional method (planning target volume, rectum, and bladder). The isodose volume method (5%, 50% and 95% isodose volume) and the error detection rates (measurement above the tolerance values, as set from the other 30 cases) were assessed and compared.
RESULTS: There was significantly higher multileaf collimator systematic closed error detectability with the isodose volume method compared to the conventional method (A-side 0.2 mm: p=0.005, A-side 0.35 mm: p=0.002, B-side 0.2 mm: p=0.001 and B-side 0.35 mm: p=0.010). There were no error types for which the error detection rate of the isodose volume method was lower than that of the conventional method.
CONCLUSION: The isodose volume method was able to evaluate the irradiated ROIs that could be delineated, and improved error detectability. This method has the potential to provide a wider margin of safety in intensity-modulated radiation therapy.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  IMRT verification; error detection; isodose volume

Mesh:

Year:  2022        PMID: 35738601      PMCID: PMC9301393          DOI: 10.21873/invivo.12908

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  25 in total

Review 1.  Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Authors:  Alan Pollack; Alex Hanlon; Eric M Horwitz; Steven Feigenberg; Robert G Uzzo; Robert A Price
Journal:  World J Urol       Date:  2003-09-05       Impact factor: 4.226

2.  A technique for the quantitative evaluation of dose distributions.

Authors:  D A Low; W B Harms; S Mutic; J A Purdy
Journal:  Med Phys       Date:  1998-05       Impact factor: 4.071

Review 3.  Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218.

Authors:  Moyed Miften; Arthur Olch; Dimitris Mihailidis; Jean Moran; Todd Pawlicki; Andrea Molineu; Harold Li; Krishni Wijesooriya; Jie Shi; Ping Xia; Nikos Papanikolaou; Daniel A Low
Journal:  Med Phys       Date:  2018-03-23       Impact factor: 4.071

4.  MapCHECK used for rotational IMRT measurements: step-and-shoot, TomoTherapy, RapidArc.

Authors:  Paul A Jursinic; Renu Sharma; Jim Reuter
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

5.  On-line quality assurance of rotational radiotherapy treatment delivery by means of a 2D ion chamber array and the Octavius phantom.

Authors:  Ann Van Esch; Christian Clermont; Magali Devillers; Mauro Iori; Dominique P Huyskens
Journal:  Med Phys       Date:  2007-10       Impact factor: 4.071

6.  Patient-specific point dose measurement for IMRT monitor unit verification.

Authors:  Lei Dong; John Antolak; Mohammad Salehpour; Kenneth Forster; Laura O'Neill; Robin Kendall; Isaac Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

7.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Michael J Zelefsky; Emily J Levin; Margie Hunt; Yoshiya Yamada; Alison M Shippy; Andrew Jackson; Howard I Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-15       Impact factor: 7.038

8.  Clinical commissioning and use of the Novalis Tx linear accelerator for SRS and SBRT.

Authors:  Jinkoo Kim; Ning Wen; Jian-Yue Jin; Nicole Walls; Sangroh Kim; Haisen Li; Lei Ren; Yimei Huang; Anthony Doemer; Kathleen Faber; Tina Kunkel; Ahssan Balawi; Kimberly Garbarino; Kenneth Levin; Samir Patel; Munther Ajlouni; Brett Miller; Teamor Nurushev; Calvin Huntzinger; Raymond Schulz; Indrin J Chetty; Benjamin Movsas; Samuel Ryu
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102

9.  Dosimetric characterization and use of GAFCHROMIC EBT3 film for IMRT dose verification.

Authors:  Valeria Casanova Borca; Massimo Pasquino; Giuliana Russo; Pierangelo Grosso; Domenico Cante; Piera Sciacero; Giuseppe Girelli; Maria Rosa La Porta; Santi Tofani
Journal:  J Appl Clin Med Phys       Date:  2013-03-04       Impact factor: 2.102

10.  Evaluation of complexity and deliverability of prostate cancer treatment plans designed with a knowledge-based VMAT planning technique.

Authors:  Phillip D H Wall; Jonas D Fontenot
Journal:  J Appl Clin Med Phys       Date:  2019-12-09       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.